Skip to main content

EnPlusOne Biosciences

Watertown, United States

EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.

$10.0M raised
Feb 2025
Venture - Series Unknown

Top Investors

CoatueBreakout VenturesNorthpond Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about EnPlusOne Biosciences

How much funding has EnPlusOne Biosciences raised?
EnPlusOne Biosciences has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
Who are EnPlusOne Biosciences's investors?
EnPlusOne Biosciences's investors include Coatue, Breakout Ventures, Northpond Ventures.
Where is EnPlusOne Biosciences headquartered?
EnPlusOne Biosciences is headquartered in Watertown, United States.
What does EnPlusOne Biosciences do?
EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.
What stage is EnPlusOne Biosciences at?
EnPlusOne Biosciences is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"EnPlusOne Biosciences — Funding & Investors." VCBacked, February 19, 2025, https://www.vcbacked.co/company/enplusone-biosciences. Accessed June 4, 2026.
APA
VCBacked. (2025). EnPlusOne Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/enplusone-biosciences
Wikipedia (cite web)
{{cite web |title=EnPlusOne Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/enplusone-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .